Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings

被引:127
作者
Pandey, Sarvesh Kumar [1 ]
Singh, Abhishek [1 ]
Singh, Ashutosh [1 ]
Nizamuddin [1 ]
机构
[1] DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273001, Uttar Pradesh, India
关键词
Quinazolinone; Antibacterial; Antifungal activity; DERIVATIVES; DISCOVERY; ACID;
D O I
10.1016/j.ejmech.2008.05.033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three series of novel and new fused heterocyclic systems, viz. triazolo[4,3-a]-quinazolin-7-ones (4), [1,2,4,5]-tetrazino[4,3-a]-quinazolin-8-ones (6) and indolo[2,3-c][1,2,4]-triazino[4,3-a]-quinazolin-8-ones (8) have been synthesized from the key intermediate 3-(substituted-phenyl)-2-hydrazino-quinazolin-4-ones (3). Thus, condensation of (3) with appropriate aromatic acids in the presence of DCC in dichloromethane afforded the fused system (4), while reaction of (3) with isatin in methanol gave the corresponding Schiff base (7) which on cyclodehydration furnished another fused heterocyclic system (8). The intermediate (3) on refluxing with substituted-phenylisothiocyanate gave the substituted-thiosemicarbazide (5), which on oxidative cyclization with bromine in CCl4 furnished the novel fused system (6). The structures of intermediate and final compounds have been determined by means of IR, H-1 NMR, C-13 NMR, UV and elemental analysis. All the synthesized compounds have been screened for their antibacterial activity against Gram-negative bacteria, Escherichia coli, Pseudomonas aeruginosa and Gram-positive bacteria, Streptococcus pneumoniae, Bacillus subtilis, as well as demonstrated significant antifungal activity against fungi viz. Candida albicans, Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1188 / 1197
页数:10
相关论文
共 28 条
[1]   Characterization of potential NMDA and cholecystokinin antagonists II.: Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivatives [J].
Almási, J ;
Takács-Novák, K ;
Kökösi, J ;
Vámos, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 180 (01) :13-22
[2]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[3]   Substituted 1,2,3-triazolo[1,5-a]quinazolines: synthesis and binding to benzodiazepine and adenosine receptors [J].
Bertelli, L ;
Biagi, G ;
Giorgi, I ;
Livi, O ;
Manera, C ;
Scartoni, V ;
Lucacchini, A ;
Giannaccini, G ;
Barili, PL .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (03) :333-341
[4]  
BRAND WW, 1977, Patent No. 19774
[5]   Green chemical multi-component one-pot synthesis of fluorinated 2,3-disubstituted quinazolin-4(3H)-ones under solvent-free conditions and their anti-fungal activity [J].
Dandia, A ;
Singh, R ;
Sarawgi, P .
JOURNAL OF FLUORINE CHEMISTRY, 2005, 126 (03) :307-312
[6]  
GIRI S, 1988, AGR BIOL CHEM TOKYO, V52, P621
[7]   Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents [J].
Grover, G ;
Kini, SG .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (02) :256-262
[8]   Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template [J].
Hunt, JT ;
Mitt, T ;
Borzilleri, R ;
Gullo-Brown, J ;
Fargnoli, J ;
Fink, B ;
Han, WC ;
Mortillo, S ;
Vite, G ;
Wautlet, B ;
Wong, T ;
Yu, CA ;
Zheng, XP ;
Bhide, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (16) :4054-4059
[9]   2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONES AS POTENTIAL ANTIDEPRESSANT AGENTS [J].
KANE, JM ;
DUDLEY, MW ;
SORENSEN, SM ;
MILLER, FP .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (06) :1253-1258
[10]  
Khan Z.K., 1997, P INT WORKSH UNIDO C, P210